Large commercial laboratories found 0.6% to 9% of mouse sera from North American and European facilities to be positive for antibodies against MuRV-A/EDIM [11], [12], [14], [15], and up to 30% of mouse colonies in the USA were identified as affected in a survey performed in 2006 [13].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}